Neutrophil elastase inhibitors for the treatment of (CARDIO)PULMONARY diseases

Structure

x-ray diffraction · 1 distinct chain · 9% helix, 40% strand (DSSP).

Ligands and binding sites

• WQQ · 1-(3-chlorophenyl)-5-(3,5-dimethylisoxazol-4-yl)-6-methyl-N-[4-(methylsulfonyl)benzyl]-2-oxo-1,2-dihydropyridine-3-carboxamide · ligand · chains A
• NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 2 copies · chains A
• FUC · alpha-L-fucopyranose · sugar · chains A
• CL · Chloride ion · ion · 3 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

Modifications

Observed in the structure: 4 disulfide, 1 glycan (disulfide, N-glycosylation).

Compared structures

• 5ABW · Neutrophil elastase inhibitors for the treatment of (cardio)pulmonary diseases · the same entry in another collection · chain A against A, TM-score 1.00
• P08246 · AlphaFold monomer V2.0 prediction for neutrophil elastase (P08246) · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

• Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
• Every structure of UniProt P08246
• Elsewhere: RCSB PDB 5ABW · PDBe 5ABW · UniProt P08246